Company Analysis
Sign in

20/20 Biolabs, Inc. (AIDX)

Nasdaq: AIDX · Services-Testing Laboratories · Rockville, MD · filing with the SEC since 2002
Full chart Alerts Compare
Grade4.2
◀ Past 3.7● Present 3.8▶ Future 5.2
5 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$2.0M+16.7%
Net income-$3.7M+32.7%
Earnings per share$-0.76+34.5%
Operating cash flow-$1.9M+26.1%
Cash$1.0M-42.5%
Debtn/a
Shareholders’ equity-$19,225-101.3%
Shares, diluted4,930,287+2.7%
Return on equityn/a
The recordfrom its filings
Filings in 202663
Newest filingOct 21 · DEFA14A
Annual reportMar 31, 2026
Quarterly reportAug 14, 2026
Next report due10-Q by Nov 14
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted12
Filer category<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
2425
As filed, in USD. Nothing here is a forecast.

News

Oct 21, 2026 · SEC EDGAR · Form DEFA14A
Extra proxy material
Open the filing on sec.gov
Oct 21, 2026 · SEC EDGAR · Form DEF 14A
Proxy statement
Open the filing on sec.gov
Sep 18, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Sep 10, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Sep 2, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Aug 19, 2026 · SEC EDGAR · Form DEFA14A
Extra proxy material
Open the filing on sec.gov
Aug 19, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Aug 17, 2026 · SEC EDGAR · Form 424B3
Shelf offering
Open the filing on sec.gov
Aug 17, 2026 · SEC EDGAR · Form 424B3
Shelf offering
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton AIDX · research, not advice